ArticleProceedings of the National Academy of Sciences of the United States of America2026
Enhanced screening via a pure DNA-encoded peptide library enabled by an Fmoc modification.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Peptide-based molecules have widespread therapeutic applications due to their potent binding affinity and relative metabolic safety. Peptide therapeutics are developed using library screening that samples a diverse chemical space within primary sequences and secondary structural conformations. DNA-encoded peptide libraries (PDELs) are ideal for the development of peptide-based therapeutics as novel building blocks, and diverse chemical modifications are easily incorporated. However, current PDEL construction is limited by precipitation-based purification, which constrains libraries to three or four building blocks in length due to decreasing quality with each synthetic step. Herein, we developed a solid-phase capture-based purification method to generate longer PDELs with increased purity. We modified the conventional Fmoc protecting group with an azido handle to introduce click chemistry for selective immobilization during purification. Using this method, we achieved >95% purity in the synthesis of a five-round PDEL that showed great efficiency in identifying high nanomolar binders against transferrin receptor protein 1. This work delivers a scalable and robust platform for generating high-quality, noncanonical peptide libraries, which marks a major breakthrough in peptide-based drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.